BACKGROUND Anticoagulation can reduce quality of life, and different models of anticoagulation management might have different impacts on satisfaction with this component of medical care. Yet, to our knowledge, there are no scales measuring quality of life and satisfaction with anticoagulation that can be generalized across different models of anticoagulation management. We describe the develop...

Background: The recognition of the relationship between thromboembolism in COVID-19 and poor clinical outcomes led to use anticoagulants patients diagnosed with COVID-19. Aim: To determine effects compare effect oral, subcutaneous, combined on patient outcomes. Study design: Retrospective cohort study Place duration: A private tertiary care hospital, Lahore, from 1st April 2020 30 Sep Methodolo...

Abstract Glioblastoma (GBM) patients have a 24-30% risk of developing venous thromboembolism (VTE), including deep vein thrombosis or pulmonary embolism, over the course their diagnosis. However, very little data exists regarding impact VTE on survival in GBM patients, with without anticoagulation. This study aimed to investigate 1) demographic factors associated incidence 2) any correlation be...

BACKGROUND International normalized ratio (INR) self-testing can improve the management of anticoagulation therapy with warfarin for the patients following mechanical heart valve replacement. Several reviews and studies have demonstrated self-management as an option to improve patient's outcome considerably after mechanical heart valve replacement. We sought to analyze the security, economy and...

In recent years, the incidence of portal vein thrombosis (PVT) in patients with cirrhosis has increased; ranges from asymptomatic partial to complete occlusion. Treatment is difficult. Anticoagulation therapy may be optimal first-line treatment for acute PVT who lack variceal bleeding or mesenteric ischemia. Minimally invasive options include mechanical thrombectomy, chemical thrombolysis, and ...

Despite anticoagulation for atrial fibrillation, some patients still suffer an ischaemic stroke. The issue of whether to stop or continue warfarin, or possibly to reverse the anticoagulation is an area of uncertainty. Continued anticoagulation may, however, increase haemorrhagic transformation of the infarct. In this article we review the published evidence in an attempt to quantify the risks a...

BACKGROUND Temporary interruption of oral anticoagulation for procedures is often required, and some propose using bridging anticoagulation. However, the use and outcomes of bridging during oral anticoagulation interruptions in clinical practice are unknown. METHODS AND RESULTS The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry is a prospective, obs...

80 Introduction and objectives. To assess the degree of compliance with current guidelines for chronic anticoagulation in patients with heart failure and atrial fibrillation. Patients and method. From the INCARGAL Study database, we analyzed data from 195 consecutive patients (88 men; mean age 76 ± 10 years) with both conditions, admitted to three Galician hospitals between January and March 19...